Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
02/1996
02/21/1996EP0697414A1 Compounds and methods for inhibiting propagation of human immunodeficiency virus
02/21/1996EP0697412A1 Benzoxazolyl- and benzo-thiazolyl-oxazolidinones
02/21/1996EP0697408A1 1 substituted-phenyl-oxazolidene-2-one derivatives and their use as adhesion-receptor antagonists
02/21/1996EP0697405A1 Substituted quinoline derivatives, process for their preparation and their use
02/21/1996EP0697015A1 Optically active 3-(1-(alkylamino))alkyl pyrrolidines
02/21/1996EP0560795B1 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics, and a process for preparing them
02/21/1996EP0516785B1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF alpha
02/21/1996CN1117291A 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl|B¨pyran-2-ones useful to treat retroviral infections
02/21/1996CN1116932A Biological bacteriostat and its preparing method
02/21/1996CN1031058C Antiviral tetrahydroimidazo |1,4¨-benzodiazepin-2-ones derivatives
02/21/1996CN1031054C Process for production of bis-(hydroxymethyl)-cyclobutyl-purines and pyrimidines
02/20/1996US5493018 Process for synthesizing carbapenem intermediates using a rhodium catalyst and lewis acid
02/20/1996US5493017 Ring-metalated porphyrins
02/20/1996US5492918 Use of substituted chromans, some of which are known, as medicaments, new active compounds and processes for their preparation
02/20/1996US5492896 Pseudopeptides having an antiviral action
02/20/1996US5492889 Treatment of mast cell tumors
02/20/1996US5492689 Administering simultaneously an antiviral agent and two antiinflammatory compounds; synergistic result in treatment of cold or influenza
02/20/1996US5492314 Preloaded digressive rate mount
02/18/1996CA2156120A1 3-substituted-2-oxindoles as inhibitors of viral replication
02/17/1996CA2156128A1 Substituted quinoline derivatives, a process for their preparation, and their use
02/15/1996WO1996004386A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection
02/15/1996WO1996004385A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
02/15/1996WO1996004384A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression
02/15/1996WO1996004383A1 Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression
02/15/1996WO1996004378A2 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2
02/15/1996WO1996004299A1 Streptogramine derivatives, preparation of same and pharmaceutical compositions containing same
02/15/1996WO1996004298A1 Purified form of streptogramines, preparation of same and pharmaceutical compositions containing same
02/15/1996WO1996004295A1 5'-dithio-modified oligonucleotides
02/15/1996WO1996004286A1 Process for making quinolonyl lactam antimicrobials and novel intermediate compounds
02/15/1996WO1996004285A1 6β-SUBSTITUTED PENICILLANIC ACIDS AS β-LACTAMASE INHIBITORS
02/15/1996WO1996004263A1 Method for the preparation of (±)-calanolide a and intermediates thereof
02/15/1996WO1996004257A1 Crystalline form of an antifungal azole
02/15/1996WO1996004250A1 Benzimidazole derivatives having dopaminergic activity
02/15/1996WO1996004247A1 Process for making antimicrobial compounds
02/15/1996WO1996004242A1 Arylthio compounds as antibacterial and antiviral agents
02/15/1996WO1996004010A1 Vr-2332 viral nucleotide sequence and methods of use
02/15/1996WO1996003883A1 Cells bearing cd4 decoy receptors and related molecules and methods
02/15/1996WO1996003876A1 Method for inhibiting nucleoside and nucleobase transport and virus replication in mammalian cells
02/15/1996DE3891231C2 Astigmatism correcting laser surgical set
02/15/1996CA2328638A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression
02/15/1996CA2196450A1 Purified form of streptogramines, preparation of same and pharmaceutical compositions containing same
02/15/1996CA2196290A1 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2
02/15/1996CA2196102A1 Streptogramine derivatives, preparation of same and pharmaceutical compositions containing same
02/15/1996CA2195864A1 5'-dithio-modified oligonucleotides
02/15/1996CA2195430A1 6.beta.-substituted penicillanic acids as .beta.-lactamase inhibitors
02/15/1996CA2195312A1 Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same
02/15/1996CA2194567A1 Crystalline form of an antifungal azole
02/15/1996CA2194488A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection
02/15/1996CA2193845A1 Arylthio compounds as antibacterial and antiviral agents
02/15/1996CA2172830A1 Method for inhibiting nucleoside and nucleobase transport and virus replication in mammalian cells
02/15/1996CA2172273A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
02/14/1996EP0696640A2 Recombinant antigen from the NS3 region of hepatitis C virus
02/14/1996EP0696287A1 Ureido derivatives of naphthalenephosphonic acids and process for their preparation
02/14/1996EP0696277A1 Hiv protease inhibitors useful for the treatment of aids
02/14/1996EP0696275A1 Vitamin d amide derivatives
02/14/1996EP0696202A1 Pharmaceutical composition containing thymoctonan and azt
02/14/1996EP0696201A1 Supplemented and unsupplemented tissue sealants, methods of their production and use
02/14/1996CN1116849A Process for the manufacture of a tricyclic compound
02/14/1996CN1116628A Cyclopeptides of the formulal
02/14/1996CN1116536A Chinese medicinal herb preparation for prevention and treatment of poultry and animal diseases
02/14/1996CN1030964C Task-masking composition of bitter pharmaceutical agents
02/13/1996US5491231 Hindered N-oxide esters of rapamycin
02/13/1996US5491229 Rapamycin derivative
02/13/1996US5491166 Inhibitors of HIV protease useful for the treatment of AIDS
02/13/1996US5491128 Aglycons of A/16686 antibiotics
02/13/1996US5491073 Cloning of chicken anaemia DNA
02/13/1996US5490498 Adding fluorocarbon along with breathing gas which oxygenates the fluorocarbon; treatment of respiratory distress syndrome
02/13/1996CA2090422C Pharmaceutical composition of florfenicol
02/09/1996CA2155496A1 Nucleic acid-binding oligomers for therapy and diagnosis
02/08/1996WO1996003510A1 A polynucleotide herpes virus vaccine
02/08/1996WO1996003430A1 Organic compounds
02/08/1996WO1996003415A1 Human potassium channel 1 and 2 proteins
02/08/1996WO1996003407A1 Compounds useful as antiproliferative agents and garft inhibitors
02/08/1996WO1996003406A1 Compounds useful as antiproliferative agents and garft inhibitors
02/08/1996WO1996003383A1 INDOLIZINE sPLA2 INHIBITORS
02/08/1996WO1996003382A1 Monomeric and dimeric naphthylisoquinoline alkaloids and synthesis methods thereof
02/08/1996WO1996003381A1 Dimeric arylisoquinoline alkaloids and synthesis methods thereof
02/08/1996WO1996003376A1 1H-INDOLE-1-FUNCTIONAL sPLA2 INHIBITORS
02/08/1996WO1996003152A1 Antisense oligonucleotides against hepatitis b viral replication
02/08/1996WO1996003142A1 Drug delivery composition for the nasal administration of antiviral agents
02/08/1996WO1996003140A1 HLA binding peptides and their uses
02/08/1996WO1996003135A1 Pharmaceutical compositions, mainly vaginal suppository, containing many different active ingredients
02/08/1996WO1996003126A1 Method of treating opportunistic infections with azaspiranes
02/08/1996WO1996003123A1 Methods
02/08/1996WO1996003120A1 INDENE sPLA2 INHIBITORS
02/08/1996DE4427530A1 New 7-tri:cyclic amino-quinolone or naphthyridone derivs
02/08/1996CA2196070A1 Antisense oligonucleotides against hepatitis b viral replication
02/08/1996CA2195778A1 Method of treating opportunistic infections with azaspiranes
02/08/1996CA2195671A1 Hla binding peptides and their uses
02/08/1996CA2195647A1 Monomeric and dimeric naphthylisoquinoline alkaloids and synthesis methods thereof
02/08/1996CA2195646A1 Dimeric arylisoquinoline alkaloids and synthesis methods thereof
02/08/1996CA2195639A1 Drug delivery composition for the nasal administration of antiviral agents
02/08/1996CA2195570A1 Indolizine spla2 inhibitors
02/08/1996CA2195569A1 1h-indole-1-functional spla2 inhibitors
02/08/1996CA2195432A1 Indene spla2 inhibitors
02/08/1996CA2195420A1 Compounds useful as antiproliferative agents and garft inhibitors
02/08/1996CA2195099A1 A polynucleotide herpes virus vaccine
02/07/1996EP0695803A2 Epitopic regions of pneumococcal surface protein A
02/07/1996EP0695548A1 A stably storable and readily water soluble composition of cephalosporin for injections
02/07/1996EP0695357A1 Mammal cell lines and method of obtaining glycoproteins